- Location
2
results for "
AMR101
"-
Amarin Announced Committee Has Voted 9 to 2 Against Approval of Vascepa Capsules for Use
Oct 18, 2013Amarin, a biopharmaceutical company, has announced the outcome of the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee for the use of Vascepa (icosapent ethyl) capsules in the treatment of high ...
-
USPTO Publish Notification of a Notice of The Allowance for Amarin's Patent
Jul 6, 2012The United States Patent and Trademark Office (USPTO) has published notification of a notice of allowance for Amarin's patent application titled Highly Stable EPA in a Capsule. A notice of allowance is issued after the USPTO makes a ...
Tags: patent application, USPTO, AMR101
